Author: telegraph

Skin tags (or acrochordon) are small, noncancerous growths that are very common, with about half of all adults having at least one in their lifetime. While most skin tags are between 1-5mm, they can grow as large as a few centimeters. They are harmless and do not affect health, yet they can be unsightly and for that reason, many people with skin tags seek to have them removed.(1)

Skin tags are made up of many components, such as collagen fibers, fat, and sometimes nerve cells and tiny blood vessels. They are frequently found in areas of friction on the body, such as skin folds, neck, underarms or eyelids.(2)

There are different methods to remove skin tags, including electrocautery, in which an electric probe is used to burn off the skin tag. Excision, with scissors or scalpel, is another option. A commonly used method is cryosurgery, in which the skin tag is frozen off with a cryogenic gas.(2)

Since cryosurgery only targets the skin tag, little or no damage is done to the surrounding tissue. “Cryosurgery is a good choice for patients with medical conditions that my complicate more invasive surgical methods or have a history of bleeding problems,” states the American Society for Dermatologic Surgery. The minimally invasive procedure has few side effects and offers a quick recovery time.(3)

Hydrozid® is an FDA cleared portable cryosurgery device, designed for primary care physicians, pediatricians, dermatologists, and podiatrists, for the treatment of skin tags, warts, and a number of additional benign and premalignant skin conditions. Qualified providers, visit to set up an account and order.

(1) Cleveland Clinic, Skin Tags (Acrochordons), https://my.clevelandclinic.org/health/diseases/21528-skin-tags-acrochordons

(2) Liu, K. MD, MHS, Harvard Health Publishing, Skin Tag Removal: Optional but Effective, https://www.health.harvard.edu/blog/skin-tag-removal-optional-but-effective-2020032319079

(3) American Society for Dermatologic Surgery, Cryosurgery for Skin Conditions, https://www.asds.net/skin-experts/skin-treatments/cryosurgery/cryosurgery-for-skin-growths

Hydrozid®, a leading cryosurgery device in Europe, is now FDA cleared and available to qualified providers in the U.S. Designed for primary care physicians, pediatricians, dermatologists, podiatrists, and other medical specialties, Hydrozid is a portable and convenient alternative to liquid nitrogen, with proven effectiveness in treating warts, seborrheic keratosis, actinic keratosis, and other pre-malignant skin conditions.

The device was developed in Denmark by BIBAWO Medical, a specialty pharma company. Originally sold to Danish dermatologists, the device is now sold to dermatologists, pediatricians, primary care physicians, gynecologists, urologists, and podiatrists, in 10 European countries. “Since 2015, we’ve experienced tremendous growth, as providers have experienced how easy and convenient Hydrozid is to use, and most importantly, how effective it is in treating warts and other skin conditions,” said Christian Kjerulf-Jensen, CEO of Medilink, BIBAWO Medical’s parent company. “We’re thrilled to have FDA clearance and be coming to the U.S., to avail providers of this unique device.”

The Hydrozid® system includes a 200mL light weight cannister, which keeps the pressure (and thus the temperature) consistent from the first use to the last. The Scandinavian design of the product, emphasizing functionality and ergonomics, makes it easy and comfortable to use. Hydrozid®’s unique spray head is patented in Denmark with a patent pending in the U.S. Templates provided with the system enable providers to select a hole matching the size of an individual lesion, thus protecting surrounding skin.

Since 2015, we’ve experienced tremendous growth, as providers have experienced how easy and convenient Hydrozid is to use, and most importantly, how effective it is in treating warts and other skin conditions

Christian Kjerulf-Jensen, CEO of Medilink, BIBAWO Medical’s parent company

Hydrozid® utilizes norflurane, a medically approved gas that has no odor and is nonflammable. This propellant has been used for decades in asthma inhalers and has proven to be safe for patients. Used Hydrozid cans do not require special disposal.

BIBAWO Medical

BIBAWO Medical is a Danish specialty pharmaceutical company which produces, markets, and distributes medical devices and equipment. Headquartered in Bikerød, Denmark, the company also has offices in Portugal and India.